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Vestibular migraine (VM) is a common disorder in which genetic, epigenetic, and envi-
ronmental factors probably contribute to its development. The pathophysiology of VM is
unknown; nevertheless in the last few years, several studies are contributing to understand
the neurophysiological pathways involved in VM.The current hypotheses are mostly based
on the knowledge of migraine itself.The evidence of trigeminal innervation of the labyrinth
vessels and the localization of vasoactive neuropeptides in the perivascular afferent termi-
nals of these trigeminal fibers support the involvement of the trigemino-vascular system.
The neurogenic inflammation triggered by activation of the trigeminal-vestibulocochlear
reflex, with the subsequent inner ear plasma protein extravasation and the release of
inflammatory mediators, can contribute to a sustained activation and sensitization of the
trigeminal primary afferent neurons explaining VM symptoms. The reciprocal connections
between brainstem vestibular nuclei and the structures that modulate trigeminal nocicep-
tive inputs (rostral ventromedial medulla, ventrolateral periaqueductal gray, locus coeruleus,
and nucleus raphe magnus) are critical to understand the pathophysiology of VM. Although
cortical spreading depression can affect cortical areas involved in processing vestibular infor-
mation, functional neuroimaging techniques suggest a dysmodulation in the multimodal
sensory integration and processing of vestibular and nociceptive information, resulting
from a vestibulo-thalamo-cortical dysfunction, as the pathogenic mechanism underlying
VM. The elevated prevalence of VM suggests that multiple functional variants may confer
a genetic susceptibility leading to a dysregulation of excitatory–inhibitory balance in brain
structures involved in the processing of sensory information, vestibular inputs, and pain.
The interactions among several functional and structural neural networks could explain the
pathogenic mechanisms of VM.
Keywords: migraine, aura, vertigo,multisensory integration, vestibulo-thalamo-cortical system,Meniere’s disease,
vestibular system
Vestibular migraine (VM) is the most common cause of sponta-
neous episodic vestibular syndrome with a lifetime prevalence of
about 1% (1). VM occurs in patients with current or previous his-
tory of migraine and recurrent episodes of vestibular symptoms
accompanied by migraine features. In 2001, Neuhauser et al. pro-
posed early diagnostic criteria for VM (2), and they have proven a
high reliability in longitudinal studies (3); these criteria included:
1. Episodic vestibular symptoms of at least moderate intensity.
2. Migraine according to the International Headache Society
(IHS).
3. At least one of the following migrainous symptoms in at least
two vertiginous attacks: migrainous headaches, photophobia,
phonophobia, and visual or other auras.
4. Other causes ruled out by appropriate investigations.
Currently, the diagnosis is based on the criteria developed by
the Bárány Society and the IHS (4). The major differences between
Neuhauser and Barany Society-IHS criteria are that the new defi-
nition sets out at least five episodes of vestibular symptoms with a
duration of 5 min – 72 h. Furthermore, current diagnostic criteria
use the Bárány Society’s Classification of Vestibular Symptoms (5).
The dissemination of these criteria and the inclusion in the beta
version of the 3rd edition of the ICHD has renewed the interest in
VM (6–9).
Neuro-otological examination between episodes is usually nor-
mal, although spontaneous and positional nystagmus can be
found during the attacks. Vestibular function tests reveal nor-
mal findings in almost half of the patients, even though unilateral
vestibular hypofunction and oculo-motor disturbances are also
common.
The differential diagnosis includes benign paroxysmal posi-
tional vertigo (BPPV), Meniere’s disease (MD), labyrinth transient
ischemic attacks, superior canal dehiscence syndrome, and chronic
subjective dizziness, being the distinction between MD and VM
the major diagnostic challenge, particularly in the first years of the
disease.
The pathophysiology of VM is unknown. Several hypotheses
have been proposed to explain the concurrence of episodic vestibu-
lar symptoms and migraine. Vestibular symptoms may appear
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in any phase of a migraine attack with a variable duration. In
some episodes, there are only migraine symptoms, while in oth-
ers migraine and vestibular symptoms are observed. Interestingly,
within a single family, some members may suffer from migraine
and other relatives have all the symptoms of VM. Moreover, it is
unclear the relation between VM, MD, and BPPV (10).
We summarize the current knowledge on the pathophysiology
of VM with a particular focus on genetic studies and multisensory
integration network. Firstly, we will describe the mechanisms of
migraine itself, since current hypotheses are mostly based on its
pathophysiology.
PATHOPHYSIOLOGY OF MIGRAINE
Migraine is a complex disorder with a controversial pathophysiol-
ogy. In the last few years, several investigations have contributed
to elucidate the causal mechanisms. It is widely accepted that
the trigemino-vascular system (TVS) is the anatomical substrate
and its activation and sensitization causes headache. The elec-
trophysiological phenomenon of cortical spreading depression
(CSD) could be the neurophysiological correlate of migraine aura,
although CSD has not been linked with aura in humans (11).
The TVS involves the nociceptive pseudounipolar neurons
of the trigeminal ganglion (TG), which innervate the pia, the
dura mater, and the cranial blood vessels, mainly through the
ophthalmic division of the trigeminal nerve (12). These first-
order neurons project centrally to the trigemino-cervical complex
(TCC), including the caudal portion of the trigeminal spinal
nucleus (trigeminal nucleus caudalis) and the C1 and C2 dorsal
horns of the spinal cord. The projections of the second-order neu-
rons of TCC ascend through the quintothalamic tract and connect
to the contralateral ventroposteromedial (VPM) and posterior
thalamic nuclei, which in turn project to the primary and sec-
ondary somatosensory cortex, the insular cortex, and the anterior
cingulate cortex. Moreover, the TCC makes reciprocal connec-
tions to brainstem centers involved in the processing of nocicep-
tive information. These centers include the rostral ventromedial
medulla (RVM) – particularly the nucleus raphe magnus – the ven-
trolateral periaqueductal gray (vlPAG), and hypothalamic areas.
In fact, the modulation of the TCC depends upon descending
pathways from the cortex, and posterior hypothalamus and these
brainstem nuclei (13).
Experimental studies have demonstrated that the depolariza-
tion of the peripheral terminals of meningeal nociceptors leads to
the activation of the TVS with the release of vasoactive neuropep-
tides from their perivascular endings. These substances, mainly
substance P (SP), calcitonin gene-related peptide (CGRP), and
neurokinin A (NK-A), cause vasodilation and an increase in cere-
bral blood flow, with plasma protein extravasation and mast cell
degranulation on the dura with the release of pro-inflammatory
factors that finally result in an inflammatory reaction known as
neurogenic inflammation (11).
Pro-inflammatory mediators and the released glutamate
increase the excitability of the first-order neurons in the TG
(peripheral sensitization) producing throbbing pain. These medi-
ators also sensitize second-order and third-order trigemino-
vascular neurons (central sensitization) causing allodynia (14–16).
Functional brain imaging studies show a participation of vlPAG,
RVM, and nucleus cuneiformis in the maintenance of central
sensitization.
Cortical spreading depression consists of a transient but mas-
sive neural depolarization, which generates a wave that slowly
spread across cortex from occipital area, and it is followed by
a prolonged suppression of cortical bioelectrical activity. CSD
causes disruptions of transmembrane ionic gradients, increasing
the intracellular concentrations of Ca2+ and the extracellular con-
centrations of H+, K+, glutamate, arachidonic acid, and nitric
oxide (NO) in the synaptic cleft. These molecules are able to
activate perivascular and meningeal nociceptors of TVS (17) and
also central trigemino-vascular neurons in the spinal trigeminal
nucleus (18).
The initiation of CSD is ignited by a local increase in the extra-
cellular K+ concentration above a critical value and the release
of glutamate from apical dendrites of cortical pyramidal cells
and activation of NMDA receptors, probably due to the open-
ing of voltage-gated Ca2+ channels (19). Recently, it has been
experimentally demonstrated that CSD induces opening of neu-
ronal pannexins channels and the release of pro-inflammatory
substances that may activate the meningeal TVS (20).
Moreover, the concept of CSD as a migraine trigger is contro-
versial since aura is not present in most patients with migraine.
Some authors have postulated a silent aura mechanism, but the
initial mechanism that causes activation of TVS is not known. A
recent hypothesis proposes that migraine is a pathological brain
state (21), in which multiple partially overlapping brain networks
are involved. So, migraine headache arises from a dysfunction
within diencephalic structures and brainstem nuclei that modulate
trigeminal nociceptive inputs: RVM, vlPAG, posterior hypothala-
mus, and VPM thalamic nucleus (13). In this alternative hypoth-
esis, direct activation of the TVS would occur instead of through
activation of peripheral nociceptors and sequential sensitization
of the first-, second-, and the third-order trigemino-vascular
neurons.
ISCHEMIC EVENTS AND VM
The hypotheses to explain the pathophysiology of VM have
evolved over time from the vascular to the neurogenic the-
ory. Reversible vasospasm of the internal auditory artery or its
branches was one of the first proposed explanations (22). This
mechanism could be responsible for the sudden onset of vestibu-
lar and/or auditory symptoms, spontaneous nystagmus or even
could account for the link between VM and MD or BPPV. More-
over, a population-based study indicates that migraine could be
associated with sudden sensorineural hearing loss (23).
Central spontaneous nystagmus and ocular-motor abnormali-
ties cannot be elucidated by internal auditory artery ischemia, but
it may be the manifestation of infarction in the anterior inferior
cerebellar artery territory (AICA) (24). Meta-analyses indicate that
migraine and stroke are not only comorbid conditions (25), but
rather migraine is probably an independent cerebrovascular risk
factor, especially in young people with migraine with aura (26, 27).
Several studies have reported reduced or absent vestibular
evoked myogenic potential (VEMP) responses in patients with
VM indicating a dysfunction of the vestibulo-collic reflex (28–
31). These findings could be related with the hypoperfusion of the
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inner ear affecting the otolith organs, as well as ischemic lesions of
the descending otolith pathways in the brainstem.
CORTICAL SPREADING DEPRESSION AND VM
Although the vestibular symptoms in VM should not be consider
as a type of sensory aura, it has been postulated that they could be
explained by the mechanism of aura, i.e., CSD (32). The wave of
CSD could reach the so-called vestibular cortex or even the brain-
stem vestibular nuclei causing vestibular symptoms. However, the
duration of VM episodes (from seconds to days) does not fulfill
the characteristics of an aura, and neither explains the unilateral
canal paresis found in some patients. Aura can occur at any time
during the attack, and aura without headache can also be observed.
Furthermore, in the case of migraine with brainstem aura, previ-
ously called basilar-type, there are other brainstem symptoms such
dysarthria, tinnitus, hypacusis, diplopia, ataxia, or decreased level
of consciousness.
INVOLVEMENT OF TVS IN VM
The inner ear receives innervation from the ophthalmic branch of
the TG through the basilar artery and the AICA (33). The TG also
innervates the cochlear nucleus and the superior olivary complex
(34). In addition, experimental studies have shown that chemical
and electrical stimulation of the TG cause a significant increase
in the inner ear blood flow, and changes in vascular permeabil-
ity with plasma protein extravasation into the inner ear (35–37).
These findings open the doors to the participation of the TVS in
the pathophysiology of VM. In this sense, painful trigeminal elec-
tric stimulation in patients with migraine without aura prompts a
spontaneous nystagmus of probable peripheral origin, or modifies
pre-existing spontaneous nystagmus, mostly increasing it (38). It
has been identified the presence of vasoactive neuropeptides (e.g.,
SP, CGRP) in the trigeminal sensory fibers innervating the inner
ear and in the vestibular nuclei (36, 39).
GENETIC FACTORS
Recently, several genome-wide association studies (GWAS) have
identified common genetic variants at several loci significantly
associated with migraine susceptibility (40, 41). Three mark-
ers have shown a consistent association in independent cohorts
of patients with migraine: rs2651899 in the PRDM16 gene,
rs10166942 in the TRPM8 gene, and rs11172113 in the LRP1
gene. The common variant in the PRDM16 gene has been asso-
ciated with migraine in European, Chinese, and North Indian
populations, but the role of this gene in migraine is unknown.
Mutations in CACNA1A gene, which encodes the central pore-
forming subunit of the voltage-gated CaV2.1 (P/Q-type) calcium
channels, cause at least three neurological calcium channelopathy
syndromes: episodic ataxia type 2, familial hemiplegic migraine
type 1, and spinocerebellar ataxia type 6 (42). Accumulating evi-
dence suggests that CaV2.1 channels could be involved in migraine
and VM pathogenesis (6, 43). Thus, migraine may be conceived
as a channelopathy in which CSD would be the result of dif-
ferent mutations that would increase the susceptibility to CSD
by affecting several ionic channels, mostly involved in glutamate
homeostasis, such that the common final result would be an
increase of glutamate and K+ extracellular concentrations in the
synaptic cleft, which could contribute to TVS activation, central
sensitization, and CSD initiation (44).
Familial occurrence of VM has been reported suggesting a
genetic component. Within the same family, there can be multiple-
affected relatives, some individuals may have migraine and others
VM or benign paroxysmal vertigo of childhood, suggesting a
phenotypic heterogeneity. An autosomal dominant pattern with
moderate to high penetrance is frequently appreciated (45, 46).
However, Sanger sequencing did not identified mutations in
patients with VM in genes causing familial hemiplegic migraine,
such as CACNA1A, ATP1A2, SCN1A, or episodic ataxia type 5
(CACNB4) (45, 46).
Despite no causative mutation has been found in candidate
gene studies, several loci have been identified. Lee et al. (47)
studied 20 multicase families diagnosed with benign recurrent
vertigo (BRV), demonstrating linkage to 22q12. BRV includes
patients with recurrent episodes of spontaneous vertigo in the
absence of cochlear signs (48). Nowadays, most of the patients
previously diagnosed with BRV could be classified as VM, since
79% of the individuals diagnosed with BRV also fulfill criteria of
migraine (47).
Subsequently, the same authors studied a large pedigree with
VM (49). These investigators did not find a region of the genome
shared by all affected family members, indicating a polygenic
inheritance. Nevertheless, a region on 11q was shared by most
affected females, suggesting that may contain a susceptibility allele
that is penetrant predominantly in women.
Bahmad et al. studied a family with 10 members affected by
VM demonstrating an autosomal dominant trait. Genome-wide
linkage analysis and subsequent fine mapping revealed that the
disease gene is located between markers rs244895 and D5S2073 in
chromosome 5q35 (50).
According to prevalence of VM, it is unlikely to be a monogenic
disease as familiar hemiplegic migraine or episodic ataxias, but it
would be rather polygenic as MD. The involved functional genetic
variants of multiple ionic channels and receptors, both in vestibu-
lar pathways and in the pain network, may determine the observed
clinical heterogeneity in the VM phenotype. This would explain
the concurrence of peripheral and central vestibular findings, and
the migrainous features.
MULTISENSORY INTEGRATION AND
VESTIBULO-THALAMIC-CORTICAL PROCESSING
The pathophysiology of VM has been explained by interactions
between nociceptive and vestibular pathways (51). The reciprocal
connections between the vestibular nuclei and other brainstem
structures, such as the parabrachial nucleus, the raphe nuclei, and
the locus coeruleus, may contribute to modulate the sensitivity
of trigemino-vascular reflex and pain pathways (52–54). Positron
emission tomography (PET) and functional magnetic resonance
imaging (fMRI) have revealed an activation of the dorsal brainstem
during migraine attacks, significantly at the dorsal raphe nucleus
and the vlPAG. In addition, reciprocal connections between the
trigeminal nucleus caudalis and the vestibular nuclei could explain
vestibular symptoms in migraneurs.
Some studies showed that patients with VM may have enhanced
perceptual sensitivity for head motions that dynamically modulate
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canal and otolith inputs together (55), so it has been suggested that
canal–otolith integration may be abnormal in these patients due
to an altered signal processing in the caudal cerebellar vermis (56).
Electrophysiological and neuroanatomic studies in animals,
along with functional neuroimaging techniques in humans by
PET and fMRI, have identified the vestibular thalamus and the
vestibular cortex as an essential part of the central vestibular
system (57). Multiple thalamic nuclei are involved in vestibular
processing, particularly the ventralposterolateral (VPL) and VPM
nuclei. The thalamus is a major sensory relay station in the vestibu-
lar pathways, and it participates in the multisensory integration
and processing of vestibular, visual, and proprioceptive inputs, so
thalamic function could be a key event in multimodal sensorial
sensitization. Thalamic activation has been demonstrated during
a migraine attack using fMRI.VPL has been involved in controlling
body orientation in space and theVPM receives trigeminothalamic
input. We speculate that migraine attacks may transiently sensitize
VPL and VPM nuclei and enhance the sensory perception, includ-
ing vestibular information. This hypothesis would also explain the
susceptibility to motion sickness described in migraine and VM
patients (58, 59).
Although a specific vestibular cortex has not been clearly identi-
fied in humans, several cortical areas are involved in the processing
of vestibular information, particularly the insula, the parietal oper-
culum, and the temporo-parietal junction, as well as the posterior
parietal cortex, the cingulate cortex, the somatosensory cortex,
and the lateral and medial frontal cortices (60–63). These regions
are multisensory areas where several sensory modalities converge.
Equally, a nociceptive-specific area neither has been found, but it
is worth noting that the posterior insular–opercular region has
been postulated as the primary nociceptive cortex (64) and it
also may provide a site for interaction between vestibular and
nociceptive processing (61, 65). The vestibular cortical projec-
tions strongly overlap with the somatosensory cortical projections,
probably due to intrainsular connections, giving rise to vestibular–
somatosensory interactions as proven by both caloric and gal-
vanic vestibular stimulation (66, 67). So, it has been suggested
that vestibular input could influence processing in other sensory
modalities.
This thalamo-cortical involvement has also been demonstrated
in PET studies in VM (68). Subtraction images comparing ictal
with interictal images showed an increased metabolism in the
bilateral cerebellum, frontal cortices, temporal cortex, posterior
insula, and thalami. It was also observed hypometabolism in
the bilateral occipitotemporal and posterior parietal cortices. The
cerebellar hypermetabolism is interpreted by an adaptive mech-
anism to suppress the hyperactive vestibular system, whereas the
occipitotemporal deactivation is explained by reciprocal inhibition
between visual and vestibular systems (69). This study indicates
activation of the vestibulo-thalamo-cortical pathway in VM.
Neuroimaging in migraineurs with blood oxygenation level-
dependent (BOLD) fMRI, have revealed the participation of sev-
eral cortical areas others than primary visual cortex. These include
anterior cingulate, prefrontal, and orbitofrontal cortices. Using
BOLD fMRI, caloric vestibular stimulation elicited a significant
activation in insular cortex, parietal cortex, thalamus, brainstem
(including PAG), and cerebellum, and a significantly decreased
response in anterior cingulate cortex. This pattern is observed
in both healthy volunteers and patients with migraine without
aura or VM during an interictal phase (70). Nevertheless, patients
with VM showed also an increased mediodorsal thalamic acti-
vation ipsilateral to the vestibular stimulation as compared with
both, healthy controls and patients with migraine without aura.
Moreover, the degree of thalamic activation was correlated with
frequency of migraine attacks in patients with VM.
Recently, patients with VM have been studied using MRI-based
voxel-based morphometry to analyze gray matter (GM) volume
differences between VM patients and healthy controls (71). VM
patients showed a decrease of GM volume bilaterally in the infe-
rior temporal gyrus, the cingulate cortex, and the posterior insula.
GM decrease was also observed in the left side of superior temporal
gyrus, middle temporal gyrus, supramarginal gyrus, and superior
parietal lobules,and on the right sides of the dorsolateral prefrontal
cortex and the inferior occipital gyrus. These findings are consis-
tent with above-mentioned studies that suggested that these areas
are involved in cortical processing of vestibular and nociceptive
information.
An intrinsic hypersensitivity to different sensory stimuli has
been described in migraineurs. Exposure to a specific stimulus
results not only in hypersensitivity to that stimulus, but it may also
result in further enhancement of hypersensitivity to other stim-
uli. It has been appreciated an altered central processing of sensory
stimuli in patients with migraine including trigeminal inputs (72),
in such a way that some authors interpret migraine as a disorder
of multisensory integration (73). As we have seen, multisensory
FIGURE 1 | Mechanisms involved in the pathophysiology of vestibular
migraine. An abnormal brain sensitization leading to a dysmodulation of
multimodal sensory integration in thalamo-cortical processing could interact
with the trigemino-vascular reflex. The abnormal processing of vestibular
and nociceptive information could determine a transient vestibular
dysfunction associated with migraine features.
Frontiers in Neurology | Headache Medicine and Facial Pain February 2015 | Volume 6 | Article 12 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Espinosa-Sanchez and Lopez-Escamez Pathophysiology of vestibular migraine
integration has been described in all vestibular relays, including
vestibular nuclei, thalamus, and cerebral cortex. These multimodal
sensory areas are responsible for the integration and processing
of somatosensory, visual, and vestibular information. An intrin-
sic enhanced vestibular sensory perception and these cross-modal
interactions at (vestibular) brainstem-thalamo-cortical level could
explain, at least partly, the link between migraine and some
vestibular disorders including VM.
We hypothesized that VM responds to an abnormal brain
sensitization leading to a dysmodulation of multimodal sen-
sory integration and processing at vestibulo-thalamo-cortical level
(Figure 1). At the molecular level, this may result from functional
variants affecting several ionic channels and receptors, and that can
confer susceptibility to VM. Multiple brain networks are probably
involved not only in the pain matrix and the vestibular pathways,
but also in other structures such as the limbic system.
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